speb/financial-data huggingface dataset:
Financial ratios for LDR.AX — annual report dated 2024-06-30
Operating income: -871750.6666666666
Net income: -778252.6666666666
Capital expenditures: 936141.3333333334
Depreciation & amortization: 21686
Net tangible assets: 5189615.333333333
Owner earnings: -1692708
Return on net tangible assets (%): -32.61721517445802
Buffett classification: The Gruesome
Stock price: 0.05333333333333334
Shares outstanding: 202230180
Book value: 5189615.333333333
P/B ratio: 2.0783061763216106
Market cap (USD): 10785609.600000001
Debt to equity: 0.004828103508763591
Current ratio: 12.93647225836981
Quick ratio: 12.93647225836981
Interest coverage ratio: -234.5096843615495
Free cash flow (dilution-adjusted): -1641788.6666666667
Buyback yield (%): 0
Retained earnings: -2477123.3333333335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.79261735399536
Rule of 40 score: 0
Financial ratios for LOCO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.29
Shares outstanding: 30455298
Market cap (USD): 374295612.41999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LOCO — annual report dated 2022-12-31
Total revenue: 469959000
Gross profit: 83700000
Operating income: 30189000
Net income: 20801000
Capital expenditures: 19917000
Operating cash flow: 38549000
Depreciation & amortization: 14418000
Net tangible assets: -29414000
Owner earnings: 15302000
Return on net tangible assets (%): -52.02284626368397
Capex to operating income (%): 65.97436152240881
Buffett classification: The Good
Stock price: 9.96
P/E ratio: 14.582701220133648
Shares outstanding: 30455298
Book value: 281148000
P/B ratio: 1.0789149063126895
Market cap (USD): 303334768.08000004
Debt to equity: 0.8994550912686556
Current ratio: 0.546596996190504
Quick ratio: 0.5109541254944318
Effective tax rate (%): 27.97188268291838
Interest coverage ratio: 18.001788908765654
COGS to revenue (%): 82.18993571779666
SG&A to revenue (%): 8.318385220838413
Free cash flow (dilution-adjusted): 15141000
Buyback yield (%): 0
Retained earnings: -11592000
Inventory turnover: 158.17321867321868
Receivables turnover: 43.306210836712125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.709989502652708
FCF margin (%): 3.221770409759149
Rule of 40 score: 3.221770409759149
Financial ratios for LOCO — annual report dated 2023-12-31
Total revenue: 468664000
Gross profit: 93695000
Operating income: 36435000
Net income: 25554000
Capital expenditures: 21332000
Operating cash flow: 40688000
Depreciation & amortization: 15235000
Net tangible assets: -59866000
Owner earnings: 19457000
Return on net tangible assets (%): -32.50091871847125
Capex to operating income (%): 58.54809935501578
Buffett classification: The Good
Stock price: 8.82
P/E ratio: 10.511690082178916
Shares outstanding: 30455298
Book value: 250696000
P/B ratio: 1.0714799133612025
Market cap (USD): 268615728.36
Debt to equity: 1.0902886364361617
Current ratio: 0.3462889736983508
Quick ratio: 0.3199597690855734
Effective tax rate (%): 26.733184242215724
Interest coverage ratio: 7.573269590521721
COGS to revenue (%): 80.00806547974668
SG&A to revenue (%): 8.966978474984211
Free cash flow (dilution-adjusted): 16392000
Buyback yield (%): 22.044874423972093
Retained earnings: 13962000
Inventory turnover: 196.21611721611723
Receivables turnover: 45.496942044461704
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.010505656892173
FCF margin (%): 3.4976016933240017
Revenue growth (%): -0.2755559527533253
Rule of 40 score: 3.2220457405706764
Financial ratios for LOCO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.7
Shares outstanding: 30455298
Market cap (USD): 417237582.59999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LOCO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.54
Shares outstanding: 30455298
Market cap (USD): 351454138.91999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LOCO — annual report dated 2024-12-31
Total revenue: 473008000
Gross profit: 103517000
Operating income: 41530000
Net income: 25684000
Capital expenditures: 19081000
Operating cash flow: 46781000
Depreciation & amortization: 15717000
Net tangible assets: -49893000
Owner earnings: 22320000
Return on net tangible assets (%): -44.73573447176959
Capex to operating income (%): 45.94509992776306
Buffett classification: The Good
Stock price: 11.54
P/E ratio: 13.683777406945957
Shares outstanding: 30455298
Book value: 260669000
P/B ratio: 1.3482774665188417
Market cap (USD): 351454138.91999996
Debt to equity: 1.0090191008520384
Current ratio: 0.26295963414311774
Quick ratio: 0.23734436543392634
Effective tax rate (%): 27.218113293094166
Interest coverage ratio: 7.040176301067977
COGS to revenue (%): 78.11516929946217
SG&A to revenue (%): 9.782075567432264
Free cash flow (dilution-adjusted): 23769000
Buyback yield (%): 5.848273707392196
Retained earnings: 18909000
Inventory turnover: 190.65583075335397
Receivables turnover: 47.471698113207545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.042900634446003
FCF margin (%): 5.025073571694348
Revenue growth (%): 0.926890053428469
Rule of 40 score: 5.951963625122817
Financial ratios for LOCO — quarterly report dated 2025-03-31
Total revenue: 119177000
Gross profit: 24144000
Operating income: 8994000
Net income: 5481000
Capital expenditures: 3389000
Operating cash flow: 4735000
Depreciation & amortization: 3887000
Net tangible assets: -44861000
Owner earnings: 5979000
Return on net tangible assets (%): -13.32783486770246
Capex to operating income (%): 37.68067600622637
Buffett classification: The Good
Stock price: 10.3
P/E ratio: 14.30804458128079
Shares outstanding: 30455298
Book value: 265701000
P/B ratio: 1.180611173461899
Market cap (USD): 313689569.40000004
Debt to equity: 0.9843433031866647
Current ratio: 0.3187396395914657
Quick ratio: 0.29400834179990376
Effective tax rate (%): 29.69471523858389
Interest coverage ratio: 7.6479591836734695
COGS to revenue (%): 79.74105741879725
SG&A to revenue (%): 9.450649034629164
Free cash flow (dilution-adjusted): 299000
Buyback yield (%): 0.5658460379779525
Retained earnings: 22571000
Inventory turnover: 51.369189189189186
Receivables turnover: 9.514370110170844
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7442131066153654
FCF margin (%): 0.25088733564362253
Rule of 40 score: 0.25088733564362253
Financial ratios for LOCO — quarterly report dated 2025-06-30
Total revenue: 125834000
Gross profit: 28815000
Operating income: 11354000
Net income: 7107000
Capital expenditures: 5038000
Operating cash flow: 14137000
Depreciation & amortization: 3929000
Net tangible assets: -36384000
Owner earnings: 5998000
Return on net tangible assets (%): -16.485268249780123
Capex to operating income (%): 44.37202747930245
Buffett classification: The Good
Stock price: 11.01
P/E ratio: 26.637498489037178
Shares outstanding: 30455298
Book value: 274178000
P/B ratio: 1.2229749687429334
Market cap (USD): 335312830.98
Debt to equity: 0.9421470723398668
Current ratio: 0.3493148900698135
Quick ratio: 0.326807856621861
Effective tax rate (%): 29.619726678550208
Interest coverage ratio: 9.406793703396852
COGS to revenue (%): 77.10078357200757
SG&A to revenue (%): 10.753850310726829
Free cash flow (dilution-adjusted): 7399000
Buyback yield (%): 0.02027956991722035
Retained earnings: 29656000
Inventory turnover: 56.145254629629626
Receivables turnover: 10.120968390573474
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1834573395051167
FCF margin (%): 5.879968847847164
Revenue growth (%): 5.585809342406672
Rule of 40 score: 11.465778190253836
Financial ratios for LOCO — quarterly report dated 2025-09-30
Total revenue: 121520000
Gross profit: 27856000
Operating income: 11540000
Net income: 7358000
Capital expenditures: 5384000
Operating cash flow: 15294000
Depreciation & amortization: 3973000
Net tangible assets: -27630000
Owner earnings: 5947000
Return on net tangible assets (%): -21.52370611653999
Capex to operating income (%): 46.65511265164645
Buffett classification: The Good
Stock price: 9.7
P/E ratio: 14.810808713526521
Shares outstanding: 30455298
Book value: 282932000
P/B ratio: 1.0441250569041323
Market cap (USD): 295416390.59999996
Debt to equity: 0.8918786139425727
Current ratio: 0.407344309234073
Quick ratio: 0.38249105225483176
Effective tax rate (%): 28.811919504643964
Interest coverage ratio: 10.285204991087344
COGS to revenue (%): 77.07702435813036
SG&A to revenue (%): 10.15717577353522
Free cash flow (dilution-adjusted): 8541000
Buyback yield (%): 0
Retained earnings: 37014000
Inventory turnover: 53.953917050691246
Receivables turnover: 9.723933744098584
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.165517603744056
FCF margin (%): 7.028472679394339
Revenue growth (%): -3.428326207543271
Rule of 40 score: 3.6001464718510676
Financial ratios for LOCO — quarterly report dated 2025-12-31
Total revenue: 123515000
Gross profit: 27742000
Operating income: 10445000
Net income: 6540000
Capital expenditures: 8824000
Operating cash flow: 13910000
Depreciation & amortization: 4177000
Net tangible assets: -19485000
Owner earnings: 1893000
Return on net tangible assets (%): -9.715165511932256
Capex to operating income (%): 84.48061273336525
Buffett classification: The Gruesome
Stock price: 10.46
P/E ratio: 12.02757747791286
Shares outstanding: 30455298
Book value: 291077000
P/B ratio: 1.0944266193481451
Market cap (USD): 318562417.08000004
Debt to equity: 0.8279802251637883
Current ratio: 0.32394188090390624
Quick ratio: 0.3010533770027441
Effective tax rate (%): 30.01605136436597
Interest coverage ratio: 10.823834196891191
COGS to revenue (%): 77.5395700927013
SG&A to revenue (%): 10.622191636643324
Free cash flow (dilution-adjusted): 3806000
Buyback yield (%): 0.00031391022493054216
Retained earnings: 43554000
Inventory turnover: 52.91325966850829
Receivables turnover: 11.01828724353256
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9798358129457947
FCF margin (%): 3.081407116544549
Revenue growth (%): 1.6417050691244237
Rule of 40 score: 4.723112185668973
Financial ratios for LOCO — annual report dated 2025-12-31
Total revenue: 490046000
Gross profit: 108557000
Operating income: 42333000
Net income: 26486000
Capital expenditures: 22635000
Operating cash flow: 48076000
Depreciation & amortization: 15966000
Net tangible assets: -19485000
Owner earnings: 19817000
Return on net tangible assets (%): -101.70387477546832
Capex to operating income (%): 53.468924952164976
Buffett classification: The Good
Stock price: 10.46
P/E ratio: 12.02757747791286
Shares outstanding: 30455298
Book value: 291077000
P/B ratio: 1.0944266193481451
Market cap (USD): 318562417.08000004
Debt to equity: 0.8279802251637883
Current ratio: 0.32394188090390624
Quick ratio: 0.3010533770027441
Effective tax rate (%): 29.511643379906854
Interest coverage ratio: 9.470469798657717
COGS to revenue (%): 77.84758981809871
SG&A to revenue (%): 10.255771907127086
Free cash flow (dilution-adjusted): 20045000
Buyback yield (%): 0.5782226343220587
Retained earnings: 43554000
Inventory turnover: 210.76740331491712
Receivables turnover: 43.71507582515611
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.02416366389989
FCF margin (%): 4.090432326761161
Revenue growth (%): 3.602053242228461
Rule of 40 score: 7.692485568989622
Financial ratios for MD.V — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.4921875
Shares outstanding: 112973453
Market cap (USD): 55604121.3984375
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MD.V — annual report dated 2022-09-30
Total revenue: 153585.401459854
Gross profit: 131766.42335766423
Operating income: -1154877.3722627736
Net income: -1386923.3576642335
Capital expenditures: 2803673.722627737
Operating cash flow: -871828.4671532846
Depreciation & amortization: 21818.97810218978
Net tangible assets: 27951935.03649635
Owner earnings: -4168778.102189781
Return on net tangible assets (%): -14.914094844405874
Buffett classification: The Gruesome
Stock price: 0.3138686131386861
Shares outstanding: 112973453
Book value: 27951935.03649635
P/B ratio: 1.2685640893305088
Market cap (USD): 35458821.01459853
Debt to equity: 0.002151999661776024
Current ratio: 7.815512240159299
Quick ratio: 7.815512240159299
Interest coverage ratio: -230.57155348294955
COGS to revenue (%): 14.206414082846985
SG&A to revenue (%): 588.2520958880672
Free cash flow (dilution-adjusted): -3996316.05839416
Buyback yield (%): 0
Retained earnings: -15405301.459854014
Receivables turnover: 0.6200368936273036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.126147641876666
FCF margin (%): -2602.015569454213
Rule of 40 score: -2602.015569454213
Financial ratios for MD.V — annual report dated 2023-09-30
Total revenue: 233311.85185185182
Gross profit: 211169.6296296296
Operating income: -1146436.2962962962
Net income: -821641.4814814815
Capital expenditures: 2849525.925925926
Operating cash flow: -344234.8148148148
Depreciation & amortization: 22142.22222222222
Net tangible assets: 29467454.814814813
Owner earnings: -3649025.185185185
Return on net tangible assets (%): -12.383238417152443
Buffett classification: The Gruesome
Stock price: 0.37037037037037035
Shares outstanding: 112973453
Book value: 29467454.814814813
P/B ratio: 1.4199400624377467
Market cap (USD): 41842019.62962963
Debt to equity: 0.0012847318513149874
Current ratio: 3.044313986382494
Quick ratio: 3.044313986382494
COGS to revenue (%): 9.490397528661369
SG&A to revenue (%): 420.43330973327704
Free cash flow (dilution-adjusted): -3540294.0740740737
Buyback yield (%): 0
Retained earnings: -16608102.222222222
Receivables turnover: 0.5114028991907724
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.888892909224147
FCF margin (%): -1517.408586822279
Revenue growth (%): 51.910174817518495
Rule of 40 score: -1465.4984120047604
Financial ratios for MD.V — annual report dated 2024-09-30
Total revenue: 144406.66666666666
Gross profit: 122264.44444444444
Operating income: -1435357.0370370368
Net income: -1446774.8148148148
Capital expenditures: 1329243.7037037036
Operating cash flow: -1183208.148148148
Depreciation & amortization: 22142.22222222222
Net tangible assets: 29275551.11111111
Owner earnings: -2753876.296296296
Return on net tangible assets (%): -9.406744507880854
Buffett classification: The Gruesome
Stock price: 0.2518518518518518
Shares outstanding: 112973453
Book value: 29275551.11111111
P/B ratio: 0.9718885646306206
Market cap (USD): 28452573.348148145
Debt to equity: 0.00042032292196593116
Current ratio: 3.118464020537822
Quick ratio: 3.118464020537822
COGS to revenue (%): 15.333241001492699
SG&A to revenue (%): 715.2460387075595
Free cash flow (dilution-adjusted): -3459576.2962962957
Buyback yield (%): 0
Retained earnings: -18189106.666666664
Receivables turnover: 0.4759183354612855
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.902920637050853
FCF margin (%): -2395.7178544132053
Revenue growth (%): -38.10573036882761
Rule of 40 score: -2433.823584782033
Financial ratios for MD.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 5535.555555555555
Buffett classification: The Gruesome
Stock price: 0.2518518518518518
Shares outstanding: 112973453
Market cap (USD): 28452573.348148145
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MD.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 5225.874125874127
Buffett classification: The Gruesome
Stock price: 0.20279720279720279
Shares outstanding: 112973453
Market cap (USD): 22910700.258741256
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MD.V — quarterly report dated 2025-03-31
Total revenue: 6927.272727272728
Gross profit: 3217.482517482518
Operating income: -350918.1818181818
Net income: -309586.013986014
Capital expenditures: 62837.76223776224
Operating cash flow: -470894.4055944056
Depreciation & amortization: 3709.79020979021
Net tangible assets: 28333439.86013986
Owner earnings: -368713.986013986
Return on net tangible assets (%): -1.3013385873160475
Buffett classification: The Gruesome
Stock price: 0.24475524475524474
Shares outstanding: 112973453
Book value: 28333439.86013986
P/B ratio: 0.9759085122156306
Market cap (USD): 27650845.13986014
Debt to equity: 0.006631443598768205
Current ratio: 4.082183662302791
Quick ratio: 4.082183662302791
COGS to revenue (%): 53.55340197859883
SG&A to revenue (%): 2819.291338582677
Free cash flow (dilution-adjusted): -558094.4055944056
Buyback yield (%): 0
Retained earnings: -18078911.88811189
Receivables turnover: 0.03676637061065728
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2310008719813355
FCF margin (%): -8056.480920654149
Rule of 40 score: -8056.480920654149
Financial ratios for MD.V — quarterly report dated 2025-06-30
Total revenue: 46191.970802919706
Gross profit: 40025.54744525547
Operating income: -244956.20437956203
Net income: -137018.24817518247
Capital expenditures: 994582.4817518247
Operating cash flow: 205662.77372262772
Depreciation & amortization: 6166.423357664233
Net tangible assets: 29482878.832116786
Owner earnings: -1125434.306569343
Return on net tangible assets (%): -3.8172469960544215
Buffett classification: The Gruesome
Stock price: 0.23357664233576642
Shares outstanding: 112973453
Book value: 29482878.832116786
P/B ratio: 0.8950265669467846
Market cap (USD): 26387959.824817516
Debt to equity: 0.006527430592898355
Current ratio: 2.7633550995590923
Quick ratio: 2.7633550995590923
COGS to revenue (%): 13.349556752998435
SG&A to revenue (%): 419.37803201491715
Free cash flow (dilution-adjusted): -821242.3357664234
Buyback yield (%): 0
Retained earnings: -19007707.29927007
Receivables turnover: 0.24251377679673192
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8258933856027529
FCF margin (%): -1777.8897966278464
Revenue growth (%): 566.8132268138015
Rule of 40 score: -1211.076569814045
Financial ratios for MD.V — quarterly report dated 2025-09-30
Total revenue: 61825.179856115115
Gross profit: 55747.48201438849
Operating income: -275802.1582733813
Net income: -572845.3237410072
Capital expenditures: 990726.618705036
Operating cash flow: -1129249.64028777
Depreciation & amortization: 6077.697841726619
Net tangible assets: 32035753.237410076
Owner earnings: -1557494.2446043165
Return on net tangible assets (%): -4.861737550111782
Buffett classification: The Gruesome
Stock price: 0.3956834532374101
Shares outstanding: 112973453
Book value: 32035753.237410076
P/B ratio: 1.3953699067388667
Market cap (USD): 44701726.00719425
Debt to equity: 0.0058054964982133155
Current ratio: 4.550538693621561
Quick ratio: 4.550538693621561
COGS to revenue (%): 9.830457195387318
SG&A to revenue (%): 393.39167064244737
Free cash flow (dilution-adjusted): -2255236.690647482
Buyback yield (%): 0
Retained earnings: -19411658.992805757
Receivables turnover: 0.16399377130142398
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8563787793285689
FCF margin (%): -3647.764059718165
Revenue growth (%): 33.84399665451656
Rule of 40 score: -3613.9200630636483
Financial ratios for MD.V — annual report dated 2025-09-30
Total revenue: 118336.69064748203
Gross profit: 96988.4892086331
Operating income: -1281445.3237410074
Net income: -1528234.5323741008
Capital expenditures: 2084253.9568345326
Operating cash flow: -1680321.582733813
Depreciation & amortization: 21348.201438848922
Net tangible assets: 32035753.237410076
Owner earnings: -3591140.287769784
Return on net tangible assets (%): -11.209788829239056
Buffett classification: The Gruesome
Stock price: 0.3956834532374101
Shares outstanding: 112973453
Book value: 32035753.237410076
P/B ratio: 1.3953699067388667
Market cap (USD): 44701726.00719425
Debt to equity: 0.0058054964982133155
Current ratio: 4.550538693621561
Quick ratio: 4.550538693621561
COGS to revenue (%): 18.040221779096346
SG&A to revenue (%): 769.7582802392878
Free cash flow (dilution-adjusted): -4022835.2517985613
Buyback yield (%): 0
Retained earnings: -19411658.992805757
Receivables turnover: 0.3138928221118799
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.978948493339405
FCF margin (%): -3399.482637031272
Revenue growth (%): -18.053166533759725
Rule of 40 score: -3417.535803565032
Financial ratios for MD.V — quarterly report dated 2025-12-31
Total revenue: 154671.53284671533
Gross profit: 148505.10948905107
Operating income: -280105.8394160584
Net income: -399340.1459854014
Capital expenditures: 308909.48905109486
Operating cash flow: -377718.24817518244
Depreciation & amortization: 6166.423357664233
Net tangible assets: 33825556.93430657
Owner earnings: -702083.2116788321
Return on net tangible assets (%): -2.0755998579487245
Buffett classification: The Gruesome
Stock price: 0.3357664233576642
Shares outstanding: 112973453
Book value: 33825556.93430656
P/B ratio: 1.1214210699278415
Market cap (USD): 37932692.24817518
Debt to equity: 0.005465417857827149
Current ratio: 5.914297757652784
Quick ratio: 5.914297757652784
Interest coverage ratio: -72.47308781869688
COGS to revenue (%): 3.986786219915054
SG&A to revenue (%): 191.72534214252005
Free cash flow (dilution-adjusted): -472446.71532846714
Buyback yield (%): 0
Retained earnings: -20225170.072992697
Receivables turnover: 0.3472131190519886
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8239979678388598
FCF margin (%): -305.45162812647476
Revenue growth (%): 150.17562942264018
Rule of 40 score: -155.27599870383457
Financial ratios for MRP — quarterly report dated 2025-03-31
Total revenue: 82698000
Gross profit: 70594000
Operating income: 45634000
Net income: 64766000
Capital expenditures: 858938000
Operating cash flow: 713733000
Net tangible assets: 5875851000
Owner earnings: -794172000
Return on net tangible assets (%): -13.515863489390728
Capex to operating income (%): 1882.2325459087524
Buffett classification: The Gruesome
Stock price: 23.04
P/E ratio: 13.716362723651297
Shares outstanding: 154228116
Book value: 5875851000
P/B ratio: 0.6047491321069918
Market cap (USD): 3553415792.64
Debt to equity: 0.05956583990982753
Current ratio: 9.271717677020328
Quick ratio: 0.17765895934980477
Effective tax rate (%): 9.912642013307382
Interest coverage ratio: 17.994479495268138
COGS to revenue (%): 14.63638782074536
SG&A to revenue (%): 30.1821083943989
Free cash flow (dilution-adjusted): 713733000
Buyback yield (%): 0
Retained earnings: 1685000
Inventory turnover: 0.0017294086919646505
Receivables turnover: 1.7518535779350082
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7149592941339779
FCF margin (%): 863.0595661321918
Rule of 40 score: 863.0595661321918
Financial ratios for MRP — quarterly report dated 2025-06-30
Total revenue: 149002000
Gross profit: 127042000
Operating income: 126861000
Net income: 112760000
Capital expenditures: 0
Operating cash flow: -583351000
Net tangible assets: 5874249000
Owner earnings: 112760000
Return on net tangible assets (%): 1.9195645264611698
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 25.15
P/E ratio: 8.599763030773323
Shares outstanding: 154228116
Book value: 5874249000
P/B ratio: 0.6603120019937867
Market cap (USD): 3878837117.3999996
Debt to equity: 0.17213468479119629
Current ratio: 60.42037037037037
Quick ratio: 0.87894656952034
Effective tax rate (%): 4.056905588455518
Interest coverage ratio: 12.334564900340302
COGS to revenue (%): 14.73805720728581
SG&A to revenue (%): 0.12147487953181836
Free cash flow (dilution-adjusted): -1442470000
Buyback yield (%): 0
Retained earnings: -98000
Inventory turnover: 0.0027991716695274474
Receivables turnover: 3.1950680819127264
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6177358354865143
FCF margin (%): -968.0876766754809
Revenue growth (%): 80.17606229896734
Rule of 40 score: -887.9116143765136
Financial ratios for MRP — quarterly report dated 2025-12-31
Total revenue: 189501000
Gross profit: 161709000
Operating income: 160737000
Net income: 122238000
Capital expenditures: 0
Operating cash flow: 3419304000
Net tangible assets: 5856262000
Owner earnings: 122238000
Return on net tangible assets (%): 2.08730415408327
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 27.61
P/E ratio: 8.708908610170324
Shares outstanding: 154228116
Book value: 5856262000
P/B ratio: 0.727125644781603
Market cap (USD): 4258238282.7599998
Debt to equity: 0.36065018948947297
Current ratio: 1.9630782006621874
Quick ratio: 1.9630782006621874
Effective tax rate (%): 4.305688205545726
Interest coverage ratio: 4.56341027169747
COGS to revenue (%): 14.665885668149508
SG&A to revenue (%): 0.16200442214025257
Free cash flow (dilution-adjusted): 4277935000
Buyback yield (%): 0
Retained earnings: -18485000
Receivables turnover: 0.5759926321964505
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7716632419088514
FCF margin (%): 2257.4735753373334
Revenue growth (%): 27.180172078227137
Rule of 40 score: 2284.6537474155607
Financial ratios for MRP — annual report dated 2025-12-31
Total revenue: 600461000
Gross profit: 512710000
Operating income: 486068000
Net income: 404824000
Capital expenditures: 0
Operating cash flow: 3672821000
Net tangible assets: 5856262000
Owner earnings: 404824000
Return on net tangible assets (%): 6.912668866249495
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 27.61
P/E ratio: 10.518739706045096
Shares outstanding: 154228116
Book value: 5856262000
P/B ratio: 0.727125644781603
Market cap (USD): 4258238282.7599998
Debt to equity: 0.36065018948947297
Current ratio: 1.9630782006621874
Quick ratio: 1.9630782006621874
Effective tax rate (%): 5.122473293653668
Interest coverage ratio: 5.295319853582011
COGS to revenue (%): 14.613938290746608
SG&A to revenue (%): 4.269552893526807
Free cash flow (dilution-adjusted): 3672144000
Buyback yield (%): 0
Retained earnings: -18485000
Receivables turnover: 1.8251149699543159
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.35750206031064
FCF margin (%): 611.5541225824825
Rule of 40 score: 611.5541225824825
Financial ratios for N91.L — annual report dated 2022-03-31
Total revenue: 54910220.99447513
Gross profit: 45849447.513812155
Operating income: 17099447.513812155
Net income: 14178176.79558011
Capital expenditures: 96685.08287292818
Operating cash flow: 16042817.67955801
Depreciation & amortization: 1035911.6022099447
Net tangible assets: 23584254.143646408
Owner earnings: 15117403.314917125
Return on net tangible assets (%): 64.09956076134699
Capex to operating income (%): 0.5654281098546042
Buffett classification: The Great
Stock price: 0.025263157894736838
P/E ratio: 1.1170018826093777
Shares outstanding: 626883236
Book value: 23591160.220994473
P/B ratio: 0.6713128995893011
Market cap (USD): 15837050.172631577
Debt to equity: 0.3202576112412178
Current ratio: 1.0289348228580628
Quick ratio: 1.0289348228580628
Effective tax rate (%): 23.137401722201425
Interest coverage ratio: 61.900000000000006
COGS to revenue (%): 16.501069047918502
SG&A to revenue (%): 15.293673751729342
Free cash flow (dilution-adjusted): 15110497.23756906
Buyback yield (%): 7.2823846900488185
Retained earnings: 17493093.92265193
Receivables turnover: 2.987974445697106
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 49.34236747708244
FCF margin (%): 27.518551125644574
Rule of 40 score: 27.518551125644574
Financial ratios for N91.L — annual report dated 2023-03-31
Total revenue: 42023675.31003383
Gross profit: 35349492.67192785
Operating income: 11183765.501691094
Net income: 9233370.91319053
Capital expenditures: 67643.74295377677
Operating cash flow: 4165727.1702367533
Depreciation & amortization: 834272.8297632469
Net tangible assets: 19718151.07102593
Owner earnings: 10000000
Return on net tangible assets (%): 50.71469411092052
Capex to operating income (%): 0.6048387096774194
Buffett classification: The Great
Stock price: 0.018518518518518517
P/E ratio: 1.2572817580880022
Shares outstanding: 626883236
Book value: 19723788.04960537
P/B ratio: 0.5885760273644334
Market cap (USD): 11608948.814814813
Debt to equity: 0.29351243212346445
Current ratio: 1.0314284883100764
Quick ratio: 1.0314284883100764
Effective tax rate (%): 22.95390404515522
Interest coverage ratio: 52.21052631578947
COGS to revenue (%): 15.881958417169685
SG&A to revenue (%): 17.89403085177733
Free cash flow (dilution-adjusted): 3297632.4689966184
Buyback yield (%): 11.556609675154073
Retained earnings: 16228861.330326946
Receivables turnover: 2.8607060629316963
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 39.672065586882646
FCF margin (%): 7.847082494969819
Revenue growth (%): -23.468391587311046
Rule of 40 score: -15.621309092341228
Financial ratios for N91.L — annual report dated 2024-03-31
Total revenue: 36920634.920634925
Gross profit: 31137566.137566138
Operating income: 10015873.015873017
Net income: 8671957.671957674
Capital expenditures: 132275.1322751323
Operating cash flow: 9089947.089947091
Depreciation & amortization: 714285.7142857143
Net tangible assets: 19439153.43915344
Owner earnings: 9253968.253968256
Return on net tangible assets (%): 47.60479041916168
Capex to operating income (%): 1.3206550449022716
Buffett classification: The Great
Stock price: 0.018860759493670887
P/E ratio: 1.3634169344533946
Shares outstanding: 626883236
Book value: 19449735.449735403
P/B ratio: 0.6078999879132534
Market cap (USD): 11823493.944810128
Debt to equity: 0.2576169749727972
Current ratio: 1.0326383448640382
Quick ratio: 1.0326383448640382
Effective tax rate (%): 24.400369003690034
Interest coverage ratio: 48.53846153846154
COGS to revenue (%): 15.663513900831184
SG&A to revenue (%): 18.65864144453998
Free cash flow (dilution-adjusted): 8084656.084656086
Buyback yield (%): 16.9602235570241
Retained earnings: 17486772.48677249
Receivables turnover: 4.307407407407407
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 36.153552330023004
FCF margin (%): 21.897391802808826
Revenue growth (%): -12.143251040635349
Rule of 40 score: 9.754140762173478
Financial ratios for N91.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 20345231.129315387
Buffett classification: The Gruesome
Stock price: 0.021066666666666668
Shares outstanding: 626883236
Book value: 20356933.879461646
P/B ratio: 0.6487391593415436
Market cap (USD): 13206340.171733335
Debt to equity: 0.25582063811440103
Current ratio: 1.0290953017817852
Quick ratio: 1.0290953017817852
Buyback yield (%): 0
Retained earnings: 19713282.621416032
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for N91.L — annual report dated 2025-03-31
Total revenue: 38022813.68821293
Gross profit: 32297664.312873438
Operating income: 9538294.405214557
Net income: 8153177.620858229
Capital expenditures: 239000.54318305268
Operating cash flow: 17294948.397609994
Depreciation & amortization: 749592.6127104834
Net tangible assets: 20282455.187398154
Owner earnings: 8663769.69038566
Return on net tangible assets (%): 42.71558650241028
Capex to operating income (%): 2.5056947608200453
Buffett classification: The Great
Stock price: 0.017532467532467535
P/E ratio: 1.3480400517339957
Shares outstanding: 626883236
Book value: 20293318.848451853
P/B ratio: 0.5415974618984837
Market cap (USD): 10990809.981818182
Debt to equity: 0.23179871520342696
Current ratio: 1.0306069188578664
Quick ratio: 1.0306069188578664
Effective tax rate (%): 26.529613313754286
Interest coverage ratio: 53.21212121212122
COGS to revenue (%): 15.057142857142855
SG&A to revenue (%): 20.21428571428571
Free cash flow (dilution-adjusted): 16175991.309071157
Buyback yield (%): 23.77177376148853
Retained earnings: 19989136.338946223
Receivables turnover: 4.469987228607919
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 33.43488194973348
FCF margin (%): 42.54285714285714
Revenue growth (%): 2.985264933680755
Rule of 40 score: 45.52812207653789
Financial ratios for N91.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 20282455.187398154
Buffett classification: The Gruesome
Stock price: 0.017532467532467535
Shares outstanding: 626883236
Book value: 20293318.848451853
P/B ratio: 0.5415974618984837
Market cap (USD): 10990809.981818182
Debt to equity: 0.23179871520342696
Current ratio: 1.0306069188578664
Quick ratio: 1.0306069188578664
Buyback yield (%): 0
Retained earnings: 19989136.338946223
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for N91.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 21315942.028985508
Buffett classification: The Gruesome
Stock price: 0.026756756756756754
Shares outstanding: 626883236
Book value: 22666666.666666746
P/B ratio: 0.7400012762003153
Market cap (USD): 16773362.26054054
Debt to equity: 0.2086956521739123
Current ratio: 1.0284158271950559
Quick ratio: 1.0284158271950559
Buyback yield (%): 0
Retained earnings: 21536231.884057973
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PCRX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 60.17
Shares outstanding: 39347924
Market cap (USD): 2367564587.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PCRX — annual report dated 2022-12-31
Total revenue: 666823000
Gross profit: 467528000
Operating income: 60024000
Net income: 15909000
Capital expenditures: 30076000
Operating cash flow: 145274000
Depreciation & amortization: 91501000
Net tangible assets: 71221000
Owner earnings: 77334000
Return on net tangible assets (%): 108.58314261243171
Capex to operating income (%): 50.10662401705984
Buffett classification: The Good
Stock price: 38.61
P/E ratio: 95.4945845521403
Shares outstanding: 39347924
Book value: 775010000
P/B ratio: 1.9602628942078166
Market cap (USD): 1519223345.6399999
Debt to equity: 0.9850118062992735
Current ratio: 3.3722711708419615
Quick ratio: 2.7222041766481246
Effective tax rate (%): -19.598556608028865
Interest coverage ratio: 1.687204857207106
COGS to revenue (%): 29.88724144188188
R&D to revenue (%): 12.716567964812251
SG&A to revenue (%): 38.16844949859258
Free cash flow (dilution-adjusted): 67106000
Buyback yield (%): 0
Retained earnings: -148751000
Inventory turnover: 2.0746281086370404
Receivables turnover: 6.776863115745399
Capitalized R&D asset: 84797000
ROCI (R&D-adjusted, %): 7.202674373886252
FCF margin (%): 10.063540099846586
Rule of 40 score: 10.063540099846586
Financial ratios for PCRX — annual report dated 2023-12-31
Total revenue: 674978000
Gross profit: 490309000
Operating income: 87675000
Net income: 41955000
Capital expenditures: 15161000
Operating cash flow: 154649000
Depreciation & amortization: 75574000
Net tangible assets: 223629000
Owner earnings: 102368000
Return on net tangible assets (%): 45.775816195573924
Capex to operating income (%): 17.29227259766182
Buffett classification: The Great
Stock price: 33.74
P/E ratio: 31.643402592301275
Shares outstanding: 39347924
Book value: 870130000
P/B ratio: 1.525747825911071
Market cap (USD): 1327598955.76
Debt to equity: 0.673513153206992
Current ratio: 5.236992082807061
Quick ratio: 4.16541901563928
Effective tax rate (%): 32.00272280838236
Interest coverage ratio: 5.0649913344887345
COGS to revenue (%): 27.359262079652968
R&D to revenue (%): 11.297701554717339
SG&A to revenue (%): 39.91848623214386
Free cash flow (dilution-adjusted): 91593000
Buyback yield (%): 0
Retained earnings: -106796000
Inventory turnover: 1.7696568378484567
Receivables turnover: 6.394501496835803
Capitalized R&D asset: 133070990
ROCI (R&D-adjusted, %): 6.847345775291566
Rosenberg metric: 0.2686533721711853
FCF margin (%): 13.569775607501281
Revenue growth (%): 1.222963215126053
Rule of 40 score: 14.792738822627335
Financial ratios for PCRX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.05
Shares outstanding: 39347924
Market cap (USD): 592186256.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PCRX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.84
Shares outstanding: 39347924
Market cap (USD): 741314888.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PCRX — annual report dated 2024-12-31
Total revenue: 700966000
Gross profit: 530538000
Operating income: 89872000
Net income: -99560000
Capital expenditures: 10636000
Operating cash flow: 189389000
Depreciation & amortization: 78785000
Net tangible assets: 352378000
Owner earnings: -31411000
Return on net tangible assets (%): -8.91400711735693
Capex to operating income (%): 11.834609222004628
Buffett classification: The Great
Stock price: 18.84
Shares outstanding: 39347924
Book value: 778348000
P/B ratio: 0.9524208813538416
Market cap (USD): 741314888.16
Debt to equity: 0.8207806790792808
Current ratio: 2.4042656169334022
Quick ratio: 2.0000258131130613
Interest coverage ratio: 6.68740233648337
COGS to revenue (%): 24.313304782257628
R&D to revenue (%): 11.637796983020575
SG&A to revenue (%): 41.95624324146963
Free cash flow (dilution-adjusted): 127582000
Buyback yield (%): 3.372386066877991
Retained earnings: -206356000
Inventory turnover: 1.3603550390319439
Receivables turnover: 6.186595354091647
Capitalized R&D asset: 160652200
ROCI (R&D-adjusted, %): 6.449856941244432
Rosenberg metric: 0.5275450122611695
FCF margin (%): 18.20088278176117
Revenue growth (%): 3.850199562059801
Rule of 40 score: 22.05108234382097
Financial ratios for PCRX — quarterly report dated 2025-03-31
Total revenue: 168923000
Gross profit: 134617000
Operating income: 8177000
Net income: 4812000
Capital expenditures: 8548000
Operating cash flow: 35459000
Depreciation & amortization: 21168000
Net tangible assets: 342052000
Owner earnings: 17432000
Return on net tangible assets (%): 5.096301147193994
Capex to operating income (%): 104.53711630182218
Buffett classification: The Gruesome
Stock price: 24.85
P/E ratio: 50.79987070864506
Shares outstanding: 39347924
Book value: 798541000
P/B ratio: 1.224478031059144
Market cap (USD): 977795911.4000001
Debt to equity: 0.797027328590517
Current ratio: 2.41463213146423
Quick ratio: 1.9896546903397176
Effective tax rate (%): 44.727773949000685
Interest coverage ratio: 2.1892904953145917
COGS to revenue (%): 20.30866134274196
R&D to revenue (%): 15.002101549226571
SG&A to revenue (%): 51.37015089715432
Free cash flow (dilution-adjusted): 12358000
Buyback yield (%): 0
Retained earnings: -201544000
Inventory turnover: 0.25648578734093935
Receivables turnover: 1.612707050455869
Capitalized R&D asset: 25342000
ROCI (R&D-adjusted, %): 1.9326348970935832
FCF margin (%): 7.31575925125649
Rule of 40 score: 7.31575925125649
Financial ratios for PCRX — quarterly report dated 2025-06-30
Total revenue: 181099000
Gross profit: 140233000
Operating income: 9133000
Net income: -4847000
Capital expenditures: 2697000
Operating cash flow: 12012000
Depreciation & amortization: 27322000
Net tangible assets: 314904000
Owner earnings: 19778000
Capex to operating income (%): 29.530274827548453
Buffett classification: The Good
Stock price: 23.9
Shares outstanding: 39347924
Book value: 757767000
P/B ratio: 1.2410350194716846
Market cap (USD): 940415383.5999999
Debt to equity: 0.8332416164863342
Current ratio: 2.380902658032213
Quick ratio: 1.9077863355941296
Interest coverage ratio: 2.37467498699948
COGS to revenue (%): 22.565558064925813
R&D to revenue (%): 15.57159343784339
SG&A to revenue (%): 48.91136891976212
Free cash flow (dilution-adjusted): -6157000
Buyback yield (%): 5.320946559641116
Retained earnings: -206391000
Inventory turnover: 0.27581784926061165
Receivables turnover: 1.5834899927426618
Capitalized R&D asset: 45179140
ROCI (R&D-adjusted, %): 1.5351782563945544
Rosenberg metric: 0.22160839712729855
FCF margin (%): -3.3997979005958063
Revenue growth (%): 7.20801785428864
Rule of 40 score: 3.8082199536928334
Financial ratios for PCRX — quarterly report dated 2025-09-30
Total revenue: 179516000
Gross profit: 145238000
Operating income: 13153000
Net income: 5432000
Capital expenditures: 3870000
Operating cash flow: 60834000
Depreciation & amortization: 21191000
Net tangible assets: 324501000
Owner earnings: 22753000
Return on net tangible assets (%): 7.011688715905344
Capex to operating income (%): 29.422945335664867
Buffett classification: The Good
Stock price: 25.77
P/E ratio: 187.88141587548637
Shares outstanding: 39347924
Book value: 727214000
P/B ratio: 1.394357096370532
Market cap (USD): 1013996001.48
Debt to equity: 0.5848457262923981
Current ratio: 5.255524010534377
Quick ratio: 3.7829526139823306
Effective tax rate (%): 42.96514069718606
Interest coverage ratio: 3.6006022447303585
COGS to revenue (%): 19.094676797611353
R&D to revenue (%): 14.464448851355868
SG&A to revenue (%): 51.13583190356291
Free cash flow (dilution-adjusted): 42986000
Buyback yield (%): 4.9350293223012285
Retained earnings: -200959000
Inventory turnover: 0.2173896499238965
Receivables turnover: 1.5573793247041676
Capitalized R&D asset: 53222860
ROCI (R&D-adjusted, %): 1.0144015104255972
Rosenberg metric: 0.1774822695035461
FCF margin (%): 23.945497894338107
Revenue growth (%): -0.8741075323441875
Rule of 40 score: 23.07139036199392
Financial ratios for PCRX — annual report dated 2025-12-31
Total revenue: 726411000
Gross profit: 576662000
Operating income: 19191000
Net income: 7034000
Capital expenditures: 15333000
Operating cash flow: 151994000
Depreciation & amortization: 91023000
Net tangible assets: 304797000
Owner earnings: 82724000
Return on net tangible assets (%): 27.140687080253418
Capex to operating income (%): 79.89682663748631
Buffett classification: The Gruesome
Stock price: 25.88
P/E ratio: 144.77171923798693
Shares outstanding: 39347924
Book value: 693111000
P/B ratio: 1.4692080678563753
Market cap (USD): 1018324273.12
Debt to equity: 0.6033723314158915
Current ratio: 4.544108135002903
Quick ratio: 3.2764822953810433
Effective tax rate (%): 58.314566789143065
Interest coverage ratio: 1.3139120909215392
COGS to revenue (%): 20.61491359574676
R&D to revenue (%): 16.14953518049699
SG&A to revenue (%): 50.764512101276004
Free cash flow (dilution-adjusted): 79159000
Buyback yield (%): 14.565890641646421
Retained earnings: -199322000
Inventory turnover: 0.979628817961181
Receivables turnover: 5.854895259895703
Capitalized R&D asset: 197133400
ROCI (R&D-adjusted, %): 3.3387244727214216
Rosenberg metric: 0.5654044644936685
FCF margin (%): 10.897274408014196
Revenue growth (%): 3.6299906129541233
Rule of 40 score: 14.527265020968319
Financial ratios for PCRX — quarterly report dated 2025-12-31
Total revenue: 196873000
Gross profit: 156574000
Operating income: -10921000
Net income: 1637000
Capital expenditures: 218000
Operating cash flow: 43689000
Depreciation & amortization: 21342000
Net tangible assets: 304797000
Owner earnings: 22761000
Return on net tangible assets (%): 7.467593184972293
Buffett classification: The Gruesome
Stock price: 25.88
P/E ratio: 144.77171923798693
Shares outstanding: 39347924
Book value: 693111000
P/B ratio: 1.4692080678563753
Market cap (USD): 1018324273.12
Debt to equity: 0.6033723314158915
Current ratio: 4.544108135002903
Quick ratio: 3.2764822953810433
Effective tax rate (%): -186.69001751313485
Interest coverage ratio: -3.2387307236061686
COGS to revenue (%): 20.46954127787965
R&D to revenue (%): 19.023939290811843
SG&A to revenue (%): 51.61093699999492
Free cash flow (dilution-adjusted): 29972000
Buyback yield (%): 4.737979961154714
Retained earnings: -199322000
Inventory turnover: 0.2636282161150834
Receivables turnover: 1.5868025050576695
Capitalized R&D asset: 64156220
ROCI (R&D-adjusted, %): -0.33162782902907567
Rosenberg metric: 0.43657090040822616
FCF margin (%): 15.224027672662071
Revenue growth (%): 9.66877604224693
Rule of 40 score: 24.892803714909
Financial ratios for QZM.V — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.24193548387096772
Shares outstanding: 74613883
Market cap (USD): 18051745.887096774
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QZM.V — annual report dated 2022-07-31
Total revenue: 0
Gross profit: -7730.46875
Operating income: -892507.8125
Net income: -779566.40625
Capital expenditures: 58593.75
Operating cash flow: -348187.5
Depreciation & amortization: 7730.46875
Net tangible assets: 398644.53125
Owner earnings: -830429.6875
Return on net tangible assets (%): -208.3133273887098
Buffett classification: The Gruesome
Stock price: 0.1640625
Shares outstanding: 74613883
Book value: 398644.53125
P/B ratio: 30.707407778311268
Market cap (USD): 12241340.1796875
Debt to equity: 0.08100300824081605
Current ratio: 1.136585040145559
Quick ratio: 1.136585040145559
Interest coverage ratio: -214.49680811115283
Free cash flow (dilution-adjusted): -718609.375
Buyback yield (%): 0
Retained earnings: -22442302.34375
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -210.38160797616285
Rule of 40 score: 0
Financial ratios for QZM.V — annual report dated 2023-07-31
Total revenue: 0
Gross profit: -7439.84962406015
Operating income: -705121.0526315789
Net income: -684531.5789473684
Capital expenditures: 187969.92481203008
Operating cash flow: -393816.54135338345
Depreciation & amortization: 7439.84962406015
Net tangible assets: 594509.7744360901
Owner earnings: -865061.6541353384
Return on net tangible assets (%): -145.50839890830636
Buffett classification: The Gruesome
Stock price: 0.16541353383458646
Shares outstanding: 74613883
Book value: 594509.7744360903
P/B ratio: 20.76020713344412
Market cap (USD): 12342146.060150376
Debt to equity: 0.041422894708219825
Current ratio: 2.4029058949285402
Quick ratio: 2.4029058949285402
Interest coverage ratio: -171.0397592558818
Free cash flow (dilution-adjusted): -1063636.0902255639
Buyback yield (%): 0
Retained earnings: -22283138.34586466
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -115.34013132730605
Rule of 40 score: 0
Financial ratios for QZM.V — annual report dated 2024-07-31
Total revenue: 0
Gross profit: -7170.289855072464
Operating income: -1849667.391304348
Net income: -1765798.550724638
Capital expenditures: 23913.04347826087
Operating cash flow: -1693076.086956522
Depreciation & amortization: 7170.289855072464
Net tangible assets: 1942749.275362319
Owner earnings: -1782541.3043478264
Return on net tangible assets (%): -91.75354364836326
Buffett classification: The Gruesome
Stock price: 0.3623188405797102
Shares outstanding: 74613883
Book value: 1942749.2753623188
P/B ratio: 13.915339422617135
Market cap (USD): 27034015.57971015
Debt to equity: 0.008349515142518037
Current ratio: 6.224352065214699
Quick ratio: 6.224352065214699
Interest coverage ratio: -474.2736900780379
Free cash flow (dilution-adjusted): -1716989.1304347827
Buyback yield (%): 0
Retained earnings: -23241576.811594203
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -94.84899279605136
Rule of 40 score: 0
Financial ratios for QZM.V — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.2733812949640288
Shares outstanding: 74613883
Market cap (USD): 20398039.956834532
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QZM.V — quarterly report dated 2025-01-31
Total revenue: 0
Gross profit: -1705.5172413793105
Operating income: -252669.6551724138
Net income: -240976.55172413794
Capital expenditures: 0
Operating cash flow: -217771.03448275864
Depreciation & amortization: 1705.5172413793105
Net tangible assets: 1589365.5172413792
Owner earnings: -239271.03448275864
Return on net tangible assets (%): -15.054500169228236
Buffett classification: The Gruesome
Stock price: 0.3448275862068966
Shares outstanding: 74613883
Book value: 1589365.5172413795
P/B ratio: 16.188173767020455
Market cap (USD): 25728925.172413796
Debt to equity: 0.007141865329040432
Current ratio: 47.94448604128784
Quick ratio: 47.94448604128784
Interest coverage ratio: -705.9171483622351
Free cash flow (dilution-adjusted): -261283.4482758621
Buyback yield (%): 0
Retained earnings: -22422677.931034483
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.818642865438925
Rule of 40 score: 0